Delgocitinib Ointment for Atopic Dermatitis in Children
Author Information
Author(s): Tatsuki Fukuie, Hiroyuki Toyama, Mai Tanaka, Katsuyo Ohashi-Doi, Kenji Kabashima
Primary Institution: National Center for Child Health and Development, TORII Pharmaceutical Co Ltd, Graduate School of Medicine Kyoto University
Hypothesis
Is delgocitinib ointment safe and effective for treating atopic dermatitis in children?
Conclusion
Delgocitinib 0.5% ointment may be more effective than the 0.25% dose for mild atopic dermatitis, and it is well tolerated when used with other medications.
Supporting Evidence
- 46.2% of children with mild disease using 0.25% ointment achieved clear or almost clear skin.
- 71.4% of children with mild disease using 0.5% ointment achieved clear or almost clear skin.
- No significant differences in safety profiles between the two ointment doses.
Takeaway
This study looked at a cream called delgocitinib to help kids with skin problems. It found that a stronger version of the cream works better for mild cases and is safe to use with other treatments.
Methodology
Post-hoc analysis of data from two double-blind placebo-controlled trials comparing 0.25% and 0.5% delgocitinib ointment in pediatric patients.
Limitations
The study is based on post-hoc analyses of short-term treatment data from a relatively small number of patients.
Participant Demographics
Pediatric patients aged 2-15 years with atopic dermatitis.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website